BioSpace News Archive

VolitionRx Limited, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has announced the launch of its first product, the Nu.Q™ Vet Cancer Screening Test.

OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the company has received the International Organization for Standards (ISO) 13485:2016 certification for its Quality Management Systems (QMS)

VivaLNK, a leading provider of connected healthcare solutions known for its unique medical wearable sensor platform and vitals data service, announces today that Jennifer Esposito joins its Board of Directors.

New Advancements to Inpatient Solution Decrease Excess Days, Reduce Burden on Frontline Teams and Create Capacity for Covid-19 and Beyond

Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced Will Chou , M.D., Aruvant chief executive officer, and other members of the management team will participate in SVB Leerink’s Biopharma P

CEL-SCI Corporation (NYSE American: CVM) announced today its LEAPS COV-19 peptides, delivered as a therapeutic treatment following SARS-CoV-2 virus challenge, achieved a 40% survival rate in transgenic mouse models as compared to 0% survival in the two control groups in stu

Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions, today announced that Jason Blessing, president and chief executive officer, will present at the Raymond James Technology Investors Conference on Monday, December 7, 2020, at 8:30 am PT or 11:30 am ET.

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, announced today that it has been granted a new patent from the European Patent Office (EPO). European Patent Number 3209382, “Combination Immunotherapy Approach for Treatment of Cancer,” secures Calidi’s proprietary technology platform, Supernova 1 (SNV1),

ImpediMed Limited, a global medical technology company using bioimpedance spectroscopy to generate powerful data to improve patient health, announced the publication of a new study demonstrating that the company’s Lymphedema Prevention Program reduces the incidence of chronic breast cancer-related lymphedema in breast cancer patients and survivors.

Rhinostics Inc. (www.rhinostics.com), an early stage company founded by two Harvard professors to provide automated sample collection solutions for more efficient laboratory workflows, announces the appointment of Cheri Walker as President and Chief Executive Officer.